logo
Judge approves plan to close hospital system in Delaware County

Judge approves plan to close hospital system in Delaware County

Yahoo23-04-2025

(Getty Images)
Questions swirled in a Texas courtroom Tuesday about the ongoing treatment of patients in a pair of suburban Philadelphia hospitals that are slated to close after their bankrupt owner abandoned plans to transfer them to another hospital system.
U.S. Bankruptcy Judge Stacey Jernigan approved Prospect Medical Holdings' plan to begin turning new patients away in Delaware County on Wednesday and to stop providing most services by Friday.
The emergency departments at Crozer Chester Medical Center in Upland and Taylor Hospital in Ridley Park will stop receiving patients by ambulance but walk-in patients will be accepted for up to a week.
In a hearing on the request, lawyers for a nurses union asked for assurance that the company would pay wages and pension contributions owed since Prospect filed for Chapter 11 bankruptcy protection in January.
Another lawyer representing several Delaware County municipalities and the school district where one of the hospitals is located argued that the company had not given the required notice that it would stop providing emergency medical and ambulance services.
'Closing a hospital system of this size is an absolute massive undertaking, and as you would expect, there is chaos, especially given that staff and patients in the community really believed that there would be a hero … stepping up,' Patient Safety Ombudsman Suzanne Koenig testified, adding that the staff remain dedicated to ensuring an orderly transfer of longer-term patients to other facilities.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Prospect has owned Crozer Health System since 2016 and closed two of its four hospitals in recent years as the California-based parent company faced financial peril. On Monday, it notified more than 2,600 employees that it would close its remaining two hospitals. It is one of the largest employers in the county.
Attorney William Curtin, who represents Prospect in the bankruptcy case, said company officials worked tirelessly with the assistance of the Pennsylvania attorney general's office to work out a deal to give the hospitals to a new owner in exchange for assuming their liabilities.
'At the end of the day, your honor, it came down to funding, and there just wasn't funding there to support a transition or to support a long term future for these hospitals,' Curtin said.
Pennsylvania and the philanthropic organization The Foundation for Delaware County provided more than $40 million in funding to allow the hospitals to continue operations as Prospect negotiated with the University of Pennsylvania to acquire the hospitals.
While Penn offered to inject an additional $5 million for the purchase of certain assets and assumption of leases, it would have also added to Prospect's debt and the money would not be available until the deal was closed, Curtin said.
'So essentially, the $5 million was going to be too late, and it was unfortunately going to be a bridge to nowhere, because there was … nowhere to go,' he said.
In response to Prospect's announcement Monday, Delaware County issued an emergency declaration that provides greater flexibility in hiring, procurement, emergency medical services dispatch, and in tracking and potentially recouping expenses related to the ongoing hospital closures. The county filed a motion opposing approval of the closure plan.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
'To be clear, Delaware County is extremely disappointed in this outcome, and in the actions of Prospect in every step of this process,' county officials said in a statement.
Previously owned by Los Angeles-based private equity firm Leonard Green & Partners, Prospect was saddled with $1.3 billion debt as its owners took more than $645 million in dividends and fees, according to ProPublica.
Nicole Stallings, president and CEO of the Hospital + Health System Association of Pennsylvania, said that while it is unfortunate that no agreement was reached to allow Crozer to continue operating, hospitals are 'consistently called upon to help when access to care is in crisis' and 'will undoubtedly step up and take care of those in need regardless of ability to pay.'
She noted that half of the commonwealth's acute care hospitals operate at a loss, according to the Pennsylvania Health Care Cost Cost Containment Council. Crozer Health System was losing $12 million a month, according to Prospect.
Stallings said the association is ready to work with policymakers and payors to address the underlying challenges pressuring hospitals and protect Pennsylvanians' access to care.
The closures will leave Delaware County, with 576,000 people, only two hospitals. It is the fifth most populous county in the commonwealth.
Andrew Costa Kelser, who represents the Philadelphia area health care pension fund and the local affiliate of the National Union of Hospital and Health Care Employees, questioned Chief Restructuring Officer Paul Rundell about wages and pension payments.
'I think our first priority right now is patient safety, and we're focusing on that. And so as I sit here today, I can't answer anything other than focusing on patient safety issues,' Rundell said.
While Judge Jernigan denied the union's motion for additional language in the closure plan to assure the payments, she said the question remains a 'giant issue' in the resolution of the bankruptcy.
'There's going to be hell to pay if people don't get paid their post-petition wages and pension obligations,' Jernigan said. 'I've gotten assurances from the debtor that these employees will get paid their wages or their salaries as long as they continue to work.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

States sue to block the sale of genetic data collected by DNA testing company 23andMe
States sue to block the sale of genetic data collected by DNA testing company 23andMe

Los Angeles Times

time22 minutes ago

  • Los Angeles Times

States sue to block the sale of genetic data collected by DNA testing company 23andMe

Dozens of states have filed a joint lawsuit against the bankrupt DNA-testing company 23andMe to block the company's sale of its customers' genetic data without explicit consent. The suit, filed this week in U.S. Bankruptcy Court in the Eastern District of Missouri, comes months after 23andMe began a court-supervised sale process of its assets. The South San Francisco-based venture was once valued at $6 billion and has collected DNA samples from more than 15 million customers. The company's bankruptcy has raised questions over privacy standards for genetic data, which experts say is uniquely sensitive, immutable and irreplaceable if stolen. Twenty-seven states and the District of Columbia filed the lawsuit, arguing that 23andMe customers have an inherent right to their own genetic information. 'This isn't just data — it's your DNA,' said Oregon Atty. Gen. Dan Rayfield in a statement. 'It's personal, permanent, and deeply private. People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest bidder.' 23andMe announced in May that it would be sold to New York-based drug maker Regeneron Pharmaceuticals, which had agreed to comply with 23andMe's existing privacy policy. However, a competing offer from nonprofit TTAM Research Institute led the bankruptcy judge to reopen the auction last week. TTAM is run by 23andMe co-founder Anne Wojcicki, who has made several failed attempts to take the company private. In a statement, a 23andMe spokesperson said the lawsuit's claims 'are without merit' and that the sale of genetic data does not violate privacy regulations. 'Customers will continue to have the same rights and protections in the hands of the winning bidder,' the spokesperson said. 23andMe customers have the right to delete their genetic information from the company's database at any time, as outlined in the Genetic Information Privacy Act and the California Consumer Privacy Act. During a testimony in Washington earlier this week, 23andMe interim Chief Executive Joseph Selsavage said that 1.9 million customers have requested their data be deleted since the company's bankruptcy filing in March. Sara Geoghegan, senior counsel at the Electronic Privacy Information Center, said that 23andMe's privacy policy was subject to change and not adequate to protect customers' data. In an interview in March, she stressed the sensitivity of genetic data. 'I would be very concerned if I had given a swab to 23andMe,' she said. 'There is little we can do to control what happens to it.'

Oracle Shares Jump as CEO Targets ‘Dramatically Higher' Revenue Growth
Oracle Shares Jump as CEO Targets ‘Dramatically Higher' Revenue Growth

Wall Street Journal

time25 minutes ago

  • Wall Street Journal

Oracle Shares Jump as CEO Targets ‘Dramatically Higher' Revenue Growth

Oracle ORCL -0.62%decrease; red down pointing triangle logged double-digit revenue growth in the fourth quarter and set its sights on even bigger gains in the fiscal year ahead, pushing shares higher after hours. The cloud-services company said revenue was up 11% to $15.9 billion in the quarter-ended May 31, topping analyst forecasts for $15.58 billion, according to FactSet.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store